FDA Reviewers Question Patient Selection for Alzheimer's Drug Candidate

Agency's advisors will discuss efficacy, safety of investigational donanemab

Related Keywords

,Judy George ,Eli Lilly ,Central Nervous System Drugs ,Integrated Alzheimer ,Disease Rating Scale ,Medpage Today ,